Ejaculatory dysfunction in patients presenting to a men's health clinic: a retrospective cohort study
AM Kasman, HP Bhambhvani, ML Eisenberg�- Sexual Medicine, 2020 - academic.oup.com
AM Kasman, HP Bhambhvani, ML Eisenberg
Sexual Medicine, 2020•academic.oup.comIntroduction Prevalence and bother of ejaculatory dysfunction (EjD) has yet to be evaluated
in a men's health referral population. Aim To evaluate the prevalence and associated risk
factors of EjD in men presenting to a men's health clinic. Methods A retrospective review
examined patients presenting to an outpatient men's health clinic who completed the Sexual
Health Inventory for Men and the Male Sexual Health Questionnaire Ejaculatory Dysfunction
(MSHQ-EjD) Short Form. Patient factors including demographics, comorbidities, and�…
in a men's health referral population. Aim To evaluate the prevalence and associated risk
factors of EjD in men presenting to a men's health clinic. Methods A retrospective review
examined patients presenting to an outpatient men's health clinic who completed the Sexual
Health Inventory for Men and the Male Sexual Health Questionnaire Ejaculatory Dysfunction
(MSHQ-EjD) Short Form. Patient factors including demographics, comorbidities, and�…
Introduction
Prevalence and bother of ejaculatory dysfunction (EjD) has yet to be evaluated in a men’s health referral population.
Aim
To evaluate the prevalence and associated risk factors of EjD in men presenting to a men’s health clinic.
Methods
A retrospective review examined patients presenting to an outpatient men’s health clinic who completed the Sexual Health Inventory for Men and the Male Sexual Health Questionnaire Ejaculatory Dysfunction (MSHQ-EjD) Short Form. Patient factors including demographics, comorbidities, and medication were examined. Descriptive statistics and multivariable logistic regression were used.
Main Outcome Measures
The main outcomes of this study are Sexual Health Inventory for Men and MSHQ-EjD scores.
Results
A total of 63 (24%) of patients presenting to the urology clinic were characterized as having EjD based on questionnaire responses. The mean age for men with EjD was 53.8 years, while those without was 42.6 years (P < .001). Of men with EjD, 74.6% were at least moderately bothered (MSHQ-EjD ≥3). Men with EjD were more likely to have erectile dysfunction (77.8%) compared with those without (21%, P < .001) as well as a history of a pelvic cancer (20.6% vs 6%, P = .001). On multivariable regression, erectile dysfunction (odds ratio: 15.04, 95% confidence interval: 6.76–35.92, P < .0001) and alpha inhibitor prescription (odds ratio: 6.82, 95% confidence interval: 1.57–30.16, P = .01) were associated with a higher odds of EjD. ED was found to be a mediator of the relationship between EjD and age, as the age association was lost in the ED population on multivariable regression compared with the non-ED population where it remained significant.
Conclusions
EjD is common among patients presenting to a men’s health clinic and may present at varying ages, though it is more common in those aged 50 years or older; it is independent of age and race. EjD is associated with erectile dysfunction, pelvic cancer history, and use of alpha inhibitors, presenting a population that could be considered for screening.
Kasman AM, Bhambhvani HP, Eisenberg ML. Ejaculatory Dysfunction in Patients Presenting to a Men’s Health Clinic: A Retrospective Cohort Study. J Sex Med 2020;8:454–460.
Oxford University Press